High levels of IGFBP‐2 can be explained by its involvement in neural development, growth, and activity [50], while in GB patients, increased expression of the IGF signaling axis, for example, IGFBP‐2 secretion, has been associated with malignant tumor progression and TMZ resistance [49, 51]. The gene discussed is IGF1; the disease is cancer.